Vergent Bioscience Stock

vergentbio.comHealthcareFounded: 2016

Vergent Bioscience is a biopharma research and development company that specializes in the identification and treatment of cancers and tumors. Vergent Bioscience partners with scientist and healthcare organizations with their minimally invasive, robotic assisted techniques to improve the visibility of a variety of tumors that at times, can be undetectable or difficult to find. Furthermore, Vergent Bioscience’s clinical technology can aid in removing tumor tissue fully.

Register for Details

For more details on financing and valuation for Vergent Bioscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Vergent Bioscience.

Register Today

Other companies like Vergent Bioscience in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.